The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
A pilot study of sunitinib in Chinese patients with heavily pretreated metastatic breast cancer.
S. Wu
No relevant relationships to disclose
X. Zhao
No relevant relationships to disclose
B. Sun
No relevant relationships to disclose
M. Du
No relevant relationships to disclose
T. Wang
No relevant relationships to disclose
S. Zhang
No relevant relationships to disclose
S. Song
No relevant relationships to disclose
Z. Jiang
No relevant relationships to disclose